NCT05387239: An ongoing trial by Vitti Labs, LLC
This trial is ongoing. It must report results 2 weeks, 1 day ago.
Full data
| Full entry on ClinicalTrials.gov | NCT05387239 |
|---|---|
| Title | Safety and Effectiveness of VL-PX10 + VL-P22 Treatment on Pulmonary Fibrosis Secondary to Covid-19 |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Nov. 30, 2022 |
| Completion date | Nov. 30, 2024 |
| Required reporting date | Nov. 30, 2025, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |